Journal Information
Vol. 45. Issue 9.
Pages 459-465 (September 2009)
Share
Share
Download PDF
More article options
Vol. 45. Issue 9.
Pages 459-465 (September 2009)
Special Article
Full text access
Complexity in Asthma: Inflammation and Scale-Free Networks
La complejidad en el asma: inflamación y redes libres de escala
Visits
5545
Miguel Perpiñá Tordera
Servicio de Neumología, Hospital Universitario La Fe, Valencia, Spain
This item has received
Article information
Abstract
Bibliography
Download PDF
Statistics
Abstract

Our understanding of asthma has traditionally been based on linear deterministic relationships of the type stimulus-bronchial hyperresponsiveness-obstruction-symptoms. This notion however neglects the fact that nonlinear relationships may be present. To better define the disease, some authors therefore suggest that we should think in terms of complex systems with a scale-free topology. The idea of multiple inflammatory hits proposed by the group of Pavord is in its broadest sense a further contribution to this line of thought. According to this theory, the coexistence of additional inflammatory stimuli, which may or may not be localized to the lungs, are responsible for deteriorating lung function. The effects of these stimuli may be additive or act in synergy with the underlying inflammation of asthma itself. In addition to the practical implications, this hypothesis serves as a reminder that the body is made up of interconnected parts and that the pathogenesis of asthma includes distinct elements linked together. If this hypothesis proves valid, future approaches should start to look for the hubs in this network that constitutes asthma, and attempt to integrate information from genomics, proteomics, and metabolomics.

Keywords:
Asthma
Inflammation
Scale-free networks
Resumen

Tradicionalmente la interpretación del asma se ha fundamentado en relaciones deterministas directas del tipo estímulo-inflamación-hiperrespuesta bronquial-obstrucción-síntomas, olvidando, sin embargo, que en esta enfermedad no es infrecuente detectar circunstancias que no guardan linealidad. Por tal motivo algunos autores postulan que el abordaje de su patogenia debería comenzar a realizarse desde la óptica de los sistemas complejos que adoptan una topología libre de escala. La teoría de los impactos inflamatorios múltiples, propuesta por el grupo de Pavord, representa, en su sentido más amplio, una aportación adicional a esta línea de pensamiento. De acuerdo con ella, en el asma la coexistencia de estímulos inflamatorios adicionales, de localización pulmonar o extrapulmonar, agravan la evolución del proceso respiratorio. Los efectos de esos estímulos pueden ser aditivos o actuar de manera sinérgica con la propia inflamación asmática. Más allá de su interés práctico, la hipótesis viene a recordarnos que el organismo es un constructo conformado a partir de conjuntos interconectados, y que el asma incluye en su patogenia elementos de naturaleza diversa entrelazados. Si esto es así, el planteamiento futuro tendría que comenzar a centrarse en la búsqueda de los hubs de esa red llamada asma integrando la información aportada por la genómica, la proteómica y la metabolómica.

Palabras clave:
Asma
Inflamación
Redes libres de escala
Full text is only aviable in PDF
References
[1.]
L. Bertalanffy.
Teoría general de sistemas.
Limusa, (1976),
[2.]
E. Ruelas Barajas, R. Mansilla.
Las ciencias de la complejidad y la innovación médica.
Grama Editora SA, (2006),
[3.]
P. Chanez, S.E. Wenzel, G.P. Anderson, J.M. Antó, E.H. Bel, L.P. Boulet, et al.
Severe asthma in adults: what are the important questions?.
J Allergy Clin Immunol, 119 (2007), pp. 1337-1348
[4.]
I. Sabroe, L.C. Parker, P.M.A. Calverley, S.K. Doer, M.J.B. Whyte.
Pathological networking: a new approach to understanding COPD.
Thorax, 62 (2007), pp. 733-738
[5.]
K. Chung, P. Godard, E. Adelroth, J. Ayres, N. Barnes, P. Barnes, et al.
Difficult/therapy resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma.
Eur Respir J, 13 (1999), pp. 1198-1208
[6.]
American Thoracic Society.
Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions.
Am J Respir Crit Care Med, 162 (2000), pp. 2341-2351
[7.]
ENFUMOSA Study Group.
The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma.
Eur Respir J, 22 (2003), pp. 470-477
[8.]
G. Rodríguez Trigo, V. Plaza, C. Picado, J. Sánchis.
El tratamiento según la guía de la Global Initiative for Asthma (GINA) reduce la morbimortalidad de los pacientes con asma de riesgo vital.
Arch Bronconeumol, 44 (2008), pp. 192-196
[9.]
V. Plaza, J. Bolíbar, J. Giner, M.A. Llauger, A. López Viña, J. Quintano, et al.
Opinión, conocimientos y grado de seguimiento referidos por los profesionales sanitarios españoles de la Guía Española para el Manejo del Asma (GEMA). Proyecto GEMATEST.
Arch Bronconeumol, 44 (2008), pp. 245-251
[10.]
F. Morell, T. Genover, X. Muñoz, J. García Aymerich, J. Ferrer, M.J. Cruz.
Tasa y características de las agudizaciones asmáticas (ASMAB I).
Arch Bronconeumol, 44 (2008), pp. 303-311
[11.]
E. Martínez Moragón, M. Perpiñá, J. Fullana, V. Macián, A. Lloris, A. Belloch.
Percepción de la disnea y cumplimiento terapéutico en pacientes con asma.
Arch Bronconeumol, 44 (2008), pp. 459-463
[12.]
L. Bjermer.
Time for a paradigm shift in asthma treatment: from relieving bronchospasm to controlling systemic inflammation.
J Allergy Clin Immunol, 120 (2007), pp. 1269-1275
[13.]
A.H. Aamodt, L.J. Stovner, A. Langhammer, K. Hagen, J.A. Zwart.
Is headache related to asthma, hay fever, and chronic bronchitis? The Head-HUNT Study.
[14.]
E. Tollefsen, A. Langhammer, L. Bjermer, P. Romundstat, T.L. Holmen.
Allergy: a systemic disease? The HUNT and Young-HUNT study, Norway.
Pediatr Allergy Immunol, 19 (2008), pp. 730-736
[15.]
I.D. Pavord, S.S. Birring, M. Berry, R.H. Green, C.E. Brightling, A.J. Wardlaw.
Multiple inflammatory hits and the pathogenesis of severe airway disease.
Eur Respir J, 27 (2006), pp. 884-888
[16.]
D.W. Cockcroft, R.E. Ruffin, J. Dolovich, F.E. Hargreave.
Allergen-induced increase in non-allergic bronchial reactivity.
Clin Allergy, 7 (1977), pp. 503-513
[17.]
C. Lemiere, J.L. Malo, D. Gautrin.
Nonsensitizing causes of occupational asthma.
Med Clin North Am, 80 (1996), pp. 749-774
[18.]
V. Plaza, J. Serrano, C. Picado, J. Sanchis.
Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma.
Eur Respir J, 19 (2002), pp. 846-852
[19.]
U. Frey, G.N. Maksym, M. Silverman, B. Suki.
New approach to the understanding of complex chronic lung diseases.
Eur Respir Mon, 37 (2006), pp. 345-360
[20.]
U. Frey.
Asthma as a nonlinear complex dynamic system: a novel approach to understand the temporal behaviour of chronic asthma and its response to,-agonists.
Eur Respir Rev, 17 (2008), pp. 67-69
[21.]
U. Frey, B. Suki.
Complexity of chronic asthma and chronic obstructive pulmonary disease: implications for risk assessment, and disease progression and control.
Lancet, 372 (2008), pp. 1088-1099
[22.]
A.L. Barabási.
Linked: the new sciences of networks.
Perseus, (2002),
[23.]
R. Albert, A.L. Barabási.
Statistical mechanics of complex networks.
Rev Modern Phys, 74 (2002), pp. 47-97
[24.]
M.E.J. Newman.
The structure and function of complex networks.
SIAM Rev, 45 (2003), pp. 167-256
[25.]
S. Boccaletti, V. Latora, Y. Moreno, M. Chavez, D.U. Hwang.
Complex networks: structure and dynamics.
Phys Rep, 424 (2006), pp. 175-308
[26.]
A.L. Barabási, Z.N. Oltvai.
Network biology: understanding the cell's functional organization.
Nature Rev, 5 (2004), pp. 101-113
[27.]
A.J.E. Seely, P.T. Macklem.
Complex systems and the technology of variability analysis.
Crit Care, 8 (2004), pp. R367-R384
[28.]
P. Oikonomou, P. Cluzel.
Effects of topology on network evolution.
Nature Phys, 2 (2006), pp. 532-536
[29.]
J. Loscalzo, I. Kohane, A.L. Barabási.
Human disease classification in the postegenomic era: a complex systems approach to human pathobiology.
Mol Syst Biol, 3 (2007), pp. 124
[30.]
R. Albert.
Scale-free neworks in cell biology.
J Cell Biol, 118 (2005), pp. 4947-4957
[31.]
K.I. Goh, M.E. Cusick, D. Valle, B. Childs, M. Vidal, A.L. Barabási.
The human disease network.
Proc Natl Acad Sci U S A, 104 (2007), pp. 8685-8690
[32.]
D.S. Lee, J. Park, K.A. Kay, N.A. Christakis, Z.N. Oltval, A.L. Barabási.
The implications of human metabolic network topology for disease comorbidity.
Proc Natl Acad Sci U S A, 105 (2008), pp. 9880-9885
[33.]
A. Ergun, C.A. Lawrence, M.A. Kohanski, T.A. Brennen, J.J. Collins.
A network biology approach to prostate cancer.
Mol Syst Biol, 3 (2007), pp. 82
[34.]
R. Pastor Satorras, A. Vespignani.
Epidemic spreading in scale free networks.
Phys Rev Letts, 86 (2001), pp. 3200-3203
[35.]
N.A. Christakis, J.H. Fowler.
The spread of obesity in a large social network over 32 years.
N Engl J Med, 357 (2007), pp. 370-379
[36.]
The Plos Medicine Editors.
It's the network, stupid: why everything in medicine is connected.
Plos Med, 5 (2008), pp. 333-334
[37.]
X. Lu, V.V. Jain, P.W. Finn, D.L. Perkins.
Hubs in biological interaction networks exhibit low changes in expression in experimental asthma.
Mol Syst Biol, 3 (2007), pp. 98
[38.]
S. Hwang, S.W. Son, S.C. Kim, Y.J. Kim, H. Jeong, D. Lee.
A protein interaction network associated with asthma.
J Theor Biol, 252 (2008), pp. 722-731
[39.]
U. Frey, T. Brodbeck, A. Majumdar, D.R. Taylor, G.I. Town, M. Silverman, et al.
Risk of sever asthma episodes predicted from fluctuation analysis of airway function.
Nature, 438 (2005), pp. 667-670
[40.]
N.C. Thomson, M. Spears.
The influence of smoking on the treatment response in patients with asthma.
Curr Opin Allergy Clin Immunol, 5 (2005), pp. 57-63
[41.]
M.J. Holtzman, E. Agapoc, E. Kim, J. Kim, J.D. Morton.
Developing the epithelial, viral, and allergic paradigm for asthma.
Chest, 123 (2003), pp. 377S-384S
[42.]
E.L.J. Van Rensen, J.K. Sont, C.E. Evertse, L.N. Willems, T. Mauad, P.S. Hiemstra, et al.
Bronchial CD8 cell infiltrate and lung function decline in asthma.
Am J Respir Crit Care Med, 172 (2005), pp. 837-841
[43.]
R.J. Lemanski.
Is asthma an infectious disease?.
Chest, 123 (2003), pp. 385S-390S
[44.]
J. Moorman, M. Saad, S. Kosseifi, G. Krishnaswamy.
Hepatitis C virus and the lung. Implications for therapy.
Chest, 128 (2005), pp. 2882-2892
[45.]
H. Kanazawa, T. Mamoto, K. Hirata, J. Yoshikawa.
Interferon therapy induces the improvement of lung function by inhaled corticosteroid therapy in asthmatic patients with chronic hepatitis C virus infection. A preliminary study.
Chest, 123 (2003), pp. 600-603
[46.]
H. Kanazawa, J. Yoshikawa.
Accelerated decline in lung function and impaired reversibility with salbutamol in asthmatic patients with chronic hepatitis C virus infection: a 6-year follow-up study.
Am J Med, 116 (2004), pp. 749-752
[47.]
H. Kanazawa, K. Hirata, J. Yoshikawa.
Increased response to inhaled oxitropium bromide in asthmatic patients with active hepatitis C virus infection.
Chest, 125 (2004), pp. 1368-1371
[48.]
H. Kanazawa, K. Hirata, J. Yoshikawa.
Accelerated decline of lung function in COPD patients with chronic hepatitis C virus infection: a preliminary study bases on small numbers of patients.
Chest, 123 (2003), pp. 596-599
[49.]
H. Kanazawa, J. Yoshikawa.
Alterations in T-lymphocyte subsets in the airways of asthmatic patient with active hepatitis C virus infection.
Respiration, 73 (2006), pp. 318-323
[50.]
K. Kubo, S. Yamaguchi, K. Fujimoto, M. Hanaoka, M. Hayasaka, T. Honda, et al.
Bronchoalveolar lavage fluid findings in patients with chronic hepatitis C virus infection.
Thorax, 51 (1996), pp. 312-314
[51.]
D.J. Adamko, A.D. Fryer, B.S. Bochner, D.B. Jacoby.
CD8+ T lymphocytes in viral hyperreactivity and M2 muscarinic receptor dysfunction.
Am J Respir Crit Care Med, 167 (2003), pp. 550-556
[52.]
I. Sabroe, L.C. Parker, D.H. Dockrell, D.E. Davies, S.K. Dower, M.K.B. Whyte.
Targetting the networks that underpin contiguous immunity in asthma and chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 175 (2007), pp. 306-311
[53.]
J.A. Denburg, S.F. Van Eeden.
Bone marrow progenitors in inflammation and repair: new vistas in respiratory biology and pathophysiology.
Eur Respir J, 27 (2006), pp. 441-445
[54.]
I. Sabroe, L.C. Parker, S.K. Dower, M.K.B. Whyte.
Practical and conceptual models of chronic obstructive pulmonary disease.
Proc Am Thorac Soc, 4 (2007), pp. 606-610
[55.]
T. Lemberger.
Systems biology in human health and disease.
Mol Syst Biol, 3 (2007), pp. 136
[56.]
A.J. Lusis.
A thematic review series: systems biology approaches to metabolic and cardiovascular disorders.
J Lipid Res, 47 (2006), pp. 1887-1890
[57.]
R. Solé.
Redes complejas.
Del genoma a internet, Tusquets Editores, (2009),

The content of the present article is based on the talk “Multiple Inflammatory Impacts in Asthma: Scale-Free Networks” given by the author at the XXXIV Spanish Pulmonology Symposium held in Burgos, Spain (October 2008).

Copyright © 2009. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?